MedTrace Logo

Acute Caffeine Ingestion on Futsal Performance

NCT04852315 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2021-04-21

No results posted yet for this study

Summary

Caffeine supplementation has been recognized such as an useful strategy for improving performance in intermittent sports, however caffeine ingestion in futsal has been barely studied. In this randomized placebo-controlled study, we investigated the effects of acute caffeine supplementation in improving neuromuscular performance and physical match activity in futsal players.

Conditions

  • Caffeine
  • Placebo

Interventions

DIETARY_SUPPLEMENT

Caffeine

Gelatine capsule with caffeine (3 mg/kg body mass of caffeine) (Bulk Powders, London, United Kingdom). The capsule containing the treatment was ingested with 150 mL of water 60 minutes before the onset of the experiment to allow substance absorption.

DIETARY_SUPPLEMENT

Placebo

Gelatine capsule with placebo (Cellulose; Guinama, Valencia, Spain). The capsule containing the treatment was ingested with 150 mL of water 60 minutes before the onset of the experiment to allow substance absorption.

Sponsors & Collaborators

  • Universidad Rey Juan Carlos

    collaborator OTHER

  • Universidad Miguel Hernandez de Elche

    collaborator OTHER

  • University of Beira Interior

    collaborator OTHER

  • Universidad Francisco de Vitoria

    lead OTHER

Principal Investigators

  • Alvaro L López Samanes, PhD · Universidad Francisco de Vitoria

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-16
Primary Completion
2019-10-18
Completion
2019-10-18

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04852315 on ClinicalTrials.gov